Zacks Research Has Optimistic Outlook of Plexus Q2 Earnings

Plexus Corp. (NASDAQ:PLXS) – Equities research analysts at Zacks Research boosted their Q2 2026 earnings per share (EPS) estimates for Plexus in a research note issued on Wednesday, February 11th. Zacks Research analyst Team now expects that the technology company will earn $1.62 per share for the quarter, up from their previous estimate of $1.51. Zacks Research has a “Strong-Buy” rating on the stock. The consensus estimate for Plexus’ current full-year earnings is $5.90 per share. Zacks Research also issued estimates for Plexus’ Q3 2026 earnings at $1.72 EPS, Q4 2026 earnings at $1.79 EPS, FY2026 earnings at $6.64 EPS, Q1 2027 earnings at $1.71 EPS, Q3 2027 earnings at $1.87 EPS, Q4 2027 earnings at $2.06 EPS, FY2027 earnings at $7.34 EPS, Q1 2028 earnings at $1.85 EPS and FY2028 earnings at $8.06 EPS.

Several other analysts have also issued reports on the stock. Weiss Ratings raised shares of Plexus from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday, February 5th. Wall Street Zen lowered Plexus from a “buy” rating to a “hold” rating in a research note on Saturday, November 22nd. Benchmark raised their target price on Plexus from $165.00 to $195.00 and gave the stock a “buy” rating in a research note on Wednesday, January 28th. Stifel Nicolaus upped their price target on Plexus from $150.00 to $200.00 and gave the company a “hold” rating in a research report on Friday, January 30th. Finally, Sidoti lowered shares of Plexus from a “buy” rating to a “neutral” rating and set a $150.00 price objective for the company. in a research report on Friday, October 24th. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat.com, Plexus presently has an average rating of “Moderate Buy” and a consensus target price of $189.20.

Plexus Trading Up 1.1%

Shares of Plexus stock opened at $201.28 on Monday. The stock has a market capitalization of $5.39 billion, a P/E ratio of 31.30 and a beta of 0.81. Plexus has a 52-week low of $103.43 and a 52-week high of $211.84. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.75 and a current ratio of 1.59. The stock’s 50-day simple moving average is $171.66 and its 200 day simple moving average is $151.16.

Plexus (NASDAQ:PLXS) last issued its earnings results on Wednesday, January 28th. The technology company reported $1.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.77 by $0.01. The firm had revenue of $1.07 billion for the quarter, compared to analyst estimates of $1.07 billion. Plexus had a return on equity of 12.39% and a net margin of 4.28%.The business’s revenue was up 9.6% on a year-over-year basis. During the same period in the previous year, the company posted $1.73 earnings per share. Plexus has set its Q2 2026 guidance at 1.800-1.950 EPS.

Insider Activity

In related news, CEO Todd P. Kelsey sold 8,120 shares of the company’s stock in a transaction on Tuesday, February 3rd. The shares were sold at an average price of $205.65, for a total value of $1,669,878.00. Following the completion of the transaction, the chief executive officer directly owned 78,598 shares in the company, valued at approximately $16,163,678.70. The trade was a 9.36% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Michael J. Running sold 926 shares of the company’s stock in a transaction dated Monday, February 2nd. The stock was sold at an average price of $204.92, for a total value of $189,755.92. Following the completion of the transaction, the insider owned 1,295 shares of the company’s stock, valued at $265,371.40. The trade was a 41.69% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 30,951 shares of company stock worth $6,077,670. Corporate insiders own 1.78% of the company’s stock.

Institutional Trading of Plexus

Institutional investors have recently made changes to their positions in the stock. Salomon & Ludwin LLC purchased a new stake in shares of Plexus in the 3rd quarter worth about $30,000. Covestor Ltd lifted its holdings in Plexus by 207.7% in the fourth quarter. Covestor Ltd now owns 240 shares of the technology company’s stock worth $35,000 after buying an additional 162 shares during the period. Allworth Financial LP boosted its position in Plexus by 70.1% during the 3rd quarter. Allworth Financial LP now owns 250 shares of the technology company’s stock valued at $36,000 after acquiring an additional 103 shares in the last quarter. Huntington National Bank grew its holdings in shares of Plexus by 41.5% during the 2nd quarter. Huntington National Bank now owns 324 shares of the technology company’s stock worth $44,000 after acquiring an additional 95 shares during the period. Finally, Johnson Financial Group Inc. bought a new position in shares of Plexus in the 3rd quarter worth approximately $72,000. Hedge funds and other institutional investors own 94.45% of the company’s stock.

Plexus News Summary

Here are the key news stories impacting Plexus this week:

• Positive Sentiment: Zacks raised several near‑term quarterly estimates (notably Q2 2026 to $1.62 from $1.51, Q3 2026 to $1.72 from $1.65 and Q4 2026 to $1.79 from $1.70), signaling stronger expected revenue/earnings cadence for 2026. Zacks raises near-term estimates for Plexus (MarketBeat)
• Positive Sentiment: Zacks also lifted FY2026–FY2028 forecasts (FY2026 to $6.64 from $6.38; FY2027 to $7.34 from $7.08; FY2028 to $8.06 from $7.86), increasing the multi‑year earnings trajectory investors use for valuation and target setting.
• Positive Sentiment: Zacks reiterated a “Strong‑Buy” on PLXS, which can attract momentum‑driven flows and analyst‑led buying given the upgraded outlook.
• Neutral Sentiment: Fundamental context: Plexus recently posted a slight EPS beat and set Q2 2026 guidance, but the shares trade at a premium (P/E ~31x) and volume today is below average — upside depends on continued execution and revenue growth translating to margin expansion.

Plexus Company Profile

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.